John C. Flickinger
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- IL-33, ST2, and ILC Pathways
Papers in
- Oncology 8
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 3
- Co-authors
- Adam E. Snook (13 shared papers)Ulrich Rodeck (1 shared paper)Robert D. Carlson (4 shared papers)Scott A. Waldman (9 shared papers)Trevor R. Baybutt (6 shared papers)Tara S. Abraham (3 shared papers)Priyanka Prajapati (1 shared paper)Glen P. Marszalowicz (1 shared paper)
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Toxins (1 paper)Biomarkers in Medicine (1 paper)npj Vaccines (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
John C. Flickinger
17 papers receiving 521 citations
Peers
Comparison fields: 5 of 60
- Biotechnology 118
- Immunology 222
- Oncology 231
- Genetics 67
- Neurology 18
Countries citing papers authored by John C. Flickinger
This map shows the geographic impact of John C. Flickinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Flickinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Flickinger more than expected).
Fields of papers citing papers by John C. Flickinger
This network shows the impact of papers produced by John C. Flickinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Flickinger. The network helps show where John C. Flickinger may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Flickinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 117 | |
| 2 | 2018 | 94 | |
| 3 | 2017 | 91 | |
| 4 | 2020 | 69 | |
| 5 | 2019 | 50 | |
| 6 | 2020 | 27 | |
| 7 | 2018 | 18 | |
| 8 | 2021 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2019 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2019 | 6 | |
| 13 | 2021 | 4 | |
| 14 | 2015 | 2 | |
| 15 | 2021 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2012 | 1 |
About John C. Flickinger
John C. Flickinger is a scholar working on Oncology, Immunology, Biotechnology, Genetics and Surgery, having authored 17 papers that have together received 530 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Cancer Research and Treatments (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers), Virus-based gene therapy research (3 papers), Listeria monocytogenes in Food Safety (2 papers), Brain Metastases and Treatment (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biotechnology (118 citations), Immunology (222 citations), Oncology (231 citations), Genetics (67 citations) and Neurology (18 citations). John C. Flickinger has collaborated with scholars based in United States, India and France. Frequent co-authors include Adam E. Snook, Ulrich Rodeck, Robert D. Carlson, Scott A. Waldman, Trevor R. Baybutt, Tara S. Abraham, Priyanka Prajapati, Glen P. Marszalowicz, Michael S. Magee and Adam R. Hersperger. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Toxins, Biomarkers in Medicine, npj Vaccines and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.